While the prevalence of obesity was higher in the group not exposed to glucocorticoids (26% (6/23) vs 14% (13/93)), this did not reach statistical significance (p=0.16).
1
0.1600
0.1600
While the prevalence of obesity was higher in the group not exposed to glucocorticoids (26% (6/23) vs 14% (13/93)), this did not reach statistical significance (p=0.16).